The efficacy of a CBT relapse prevention program for remitted anxiety disorder patients who discontinue antidepressant medication.

Completed

• Conditions: anxiety disorders; anxiety; 10002861

• Registration Number: NL-OMON37997
• Lead Sponsor: GGZ inGeest (Amsterdam)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 220

Inclusion Criteria

Included are adults aged 18-65 years i) who use AD for panic disorder (with or without agoraphobia), social phobia or generalized anxiety disorder; ii) who are in remission; and iii) who want to discontinue AD.

Exclusion Criteria

Patients with a comorbid dementia, psychotic disorder, alcohol or drug dependence or who do not speak Dutch are excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome measure is relapse within a year. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome measures are i) time to relapse; ii) one-year course of<br /><br>anxiety symptoms; iii) quality of life; iv) patient satisfaction; v)predictors<br /><br>of relapse; vi) cost-effectivity; and vii) cost-utility. </p><br>